Key stats
About JPMorgan Healthcare Leaders ETF
Home page
Inception date
Nov 1, 2023
Structure
Open-Ended Fund
Replication method
Physical
Dividend treatment
Distributes
Distribution tax treatment
Qualified dividends
Income tax type
Capital Gains
Max ST capital gains rate
39.60%
Max LT capital gains rate
20.00%
Primary advisor
JPMorgan Investment Management, Inc.
Distributor
JPMorgan Distribution Services, Inc.
JDOC uses proprietary research to select healthcare companies considered to be leaders in the space and underappreciated by the market. The fund may be invested in companies across all market capitalizations and located anywhere around the world. Although, the adviser expects a majority of the holdings to be of mid- or large-cap companies located in the US. Companies considered for inclusion are believed to have catalysts that will lead to outperform their peers. For example, such companies may be obtaining regulatory approvals, received favorable clinical outcomes, improving sales growth, or positive research and development momentum. The adviser selects those in which the magnitude and duration of future growth is not yet realized in the stock. The fund may use derivates to manage risk or gain equity exposure. Also, as part of its investment process, the adviser seeks to assess the impact of related ESG factors.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks97.86%
Health Technology79.94%
Health Services9.20%
Distribution Services4.64%
Retail Trade2.32%
Technology Services1.76%
Bonds, Cash & Other2.14%
Cash2.14%
Stock breakdown by region
North America71.62%
Europe25.15%
Asia3.22%
Latin America0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
JDOC invests in stocks. The fund's major sectors are Health Technology, with 79.94% stocks, and Health Services, with 9.20% of the basket. The assets are mostly located in the North America region.
JDOC top holdings are Eli Lilly and Company and Johnson & Johnson, occupying 8.29% and 6.61% of the portfolio correspondingly.
JDOC last dividends amounted to 0.33 USD. The year before, the issuer paid 2.49 USD in dividends, which shows a 659.77% decrease.
JDOC assets under management is 7.51 M USD. It's risen 2.53% over the last month.
JDOC fund flows account for 1.36 M USD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
Yes, JDOC pays dividends to its holders with the dividend yield of 0.65%. The last dividend (Dec 27, 2024) amounted to 0.33 USD. The dividends are paid annually.
JDOC shares are issued by JPMorgan Chase & Co. under the brand JPMorgan. The ETF was launched on Nov 1, 2023, and its management style is Active.
JDOC expense ratio is 0.65% meaning you'd have to pay 0.65% of your investment to help manage the fund.
JDOC follows the No Underlying Index. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
JDOC invests in stocks.
JDOC price has risen by 2.40% over the last month, and its yearly performance shows a −14.35% decrease. See more dynamics on JDOC price chart.
NAV returns, another gauge of an ETF dynamics, showed a −5.23% decrease in three-month performance and has decreased by −10.11% in a year.
NAV returns, another gauge of an ETF dynamics, showed a −5.23% decrease in three-month performance and has decreased by −10.11% in a year.
JDOC trades at a premium (0.20%) meaning the ETF is trading at a higher price than the calculated NAV.